Clinical Trials · NCT07617155
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Enrollment
- 396
- Start date
- Sep 2026
- Locations
- 1 site, China
- Primary endpoint
- Proportion of participants with recurrent hypertriglyceridemia-induced acute pancreatitis